Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 140Leukemia, Myeloid, Acute 120Leukemia 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Myeloproliferative Disorders 57Lymphoma 56Lymphoma, Non-Hodgkin 55Leukemia, Lymphocytic, Chronic, B-Cell 53Leukemia, Myeloid, Chronic-Phase 52Multiple Myeloma 51Leukemia, Myelomonocytic, Chronic 50Hodgkin Disease 49Congenital Abnormalities 47Leukemia, Myeloid, Accelerated Phase 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Primary Myelofibrosis 40Blast Crisis 39Anemia, Refractory, with Excess of Blasts 38Lymphoma, Follicular 37Lymphoma, Large B-Cell, Diffuse 36Lymphoma, Mantle-Cell 35Burkitt Lymphoma 35Myelodysplastic-Myeloproliferative Diseases 34Lymphoma, B-Cell, Marginal Zone 33Neoplasms, Plasma Cell 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 31Graft vs Host Disease 24Dendritic Cell Sarcoma, Interdigitating 23Polycythemia Vera 21

Interventions

eltrombopag 3Platelet Transfusion 2Busulfan 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2siltuximab 1oprelvekin 1fludarabine phosphate 1fludarabine 1Vitamin E 1Tranexamic Acid 1Topotecan 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Microarray Analysis 1Isotretinoin 1Interleukin-11 1Hematopoietic Stem Cell Transplantation 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cytarabine 1Cyclophosphamide 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thrombocytopenia × Busulfan × Myeloid × Clear all
NCT03303950 2022-05-05

Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis

University of Utah

Phase 2 Terminated
6 enrolled 17 charts
Classical hematologyMyeloidPlasma cell

Anemia, Multiple Myeloma, Thrombocytopenia, Primary Myelofibrosis

NCT00003619 2013-06-26

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡